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Abstract
Background: Growing levels of both obesity and chronic disease in the general population pose a major public
health problem. In the UK, an innovative ‘health and weight’ cohort trials facility, the ‘South Yorkshire Cohort’,i s
being built in order to provide robust evidence to inform policy, commissioning and clinical decisions in this field.
This protocol reports the design of the facility and outlines the recruitment phase methods.
Method/Design: The South Yorkshire Cohort health and weight study uses the cohort multiple randomised
controlled trial design. This design recruits a large observational cohort of patients with the condition(s) of interest
which then provides a facility for multiple randomised controlled trials (with large representative samples of
participants, long term outcomes as standard, increased comparability between each trial conducted within the
cohort and increased efficiency particularly for trials of expensive interventions) as well as ongoing information as
to the natural history of the condition and treatment as usual.
This study aims to recruit 20,000 participants to the population based South Yorkshire Cohort health and weight
research trials facility. Participants are recruited by invitation letters from their General Practitioners. Data is
collected using postal and/or online patient self completed Health Questionnaires. NHS numbers will be used to
facilitate record linkage and access to routine data. Participants are eligible if they are: aged 16 - 85 years,
registered with one of 40 practices in South Yorkshire, provide consent for further contact from the researchers
and to have their information used to look at the benefit of health treatments. The first wave of data is being
collected during 2010/12 and further waves are planned at 2 - 5 year intervals for the planned 20 year duration of
the facility.
Discussion: The South Yorkshire Cohort combines the strengths of the standard observational, longitudinal cohort
study design with a population based cohort facility for multiple randomised controlled trials in a range of long
term health and weight related conditions (including obesity). This infrastructure will allow the rapid and cheap
identification and recruitment of patients, and facilitate the provision of robust evidence to inform the
management and self-management of health and weight.
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Growing levels of obesity and obesity related conditions
in England (and much of the developed world) pose a
major public health problem requiring the urgent atten-
tion of policy makers, health professionals and the pub-
lic alike [1]. The recent influential Foresight [2] review
of the evidence on the causes, prevention and treatment
of obesity highlighted various factors germane to assem-
bling an effective public health response to this problem.
This report identified the causes of obesity as being
“embedded in an extremely complex biological system set
within an equally complex societal framework” and high-
lighted the impact of changes in work patterns, trans-
port, food production, food sales and shifts in values on
obesity over the past five decades. Following the evi-
dence provided by Foresight, the Healthy Weight
Healthy Lives report [1] identified the following range of
requirements for a cross government research and sur-
veillance plan for England:
￿ short, medium and longer term research and
surveillance
￿ research to read across to other policy and
research agendas, e.g. vascular disease, cancer, dia-
betes, liver disease
￿ evaluate policies aimed at tackling obesity includ-
ing impact on health inequalities
￿ evaluate long term impact of interventions includ-
ing assessing cost effectiveness
￿ research to target large population groups and eva-
luation of ‘natural experiments’.
The study described here - the South Yorkshire Cohort
study [3] - focuses on fulfilling these five requirements by
building a short, medium and longer term population
based research and surveillance facility for weight and
health.
This study also seeks to address fundamental flaws in
the methodology of existing studies which have hindered
t h ea b i l i t yt oi d e n t i f ye f f e c t i ve public health and clinical
interventions (a core observation made in the National
Institute for Health and Clinical Excellence (NICE) clinical
guidelines for obesity [4].
In order to inform NHS commissioning of obesity ser-
vices, a range of information is required, namely, data
from longitudinal observational studies and randomised
controlled trials conducted in populations representative
of the ‘with need’ population. Although the information
is needed, few interventions or services currently benefit
from this level of evidence. Existing longitudinal birth
cohort studies provide long term outcome data on
weight and chronic disease in the UK e.g. [5,6] and
many other datasets provide data on adult weight and
height in the UK, e.g. Health Survey for England [7],
Quality Outcomes Framework [8], QResearch [9], how-
ever, none of these studies provide all the information
required by the NHS. Birth cohorts only collect data
on individuals born in that particular year/month, the
annual home interviews of the Health Survey for
England [7] collect cross sectional (not longitudinal)
data, Quality Outcomes Framework [8] collects data
opportunistically from those seeking treatment (and
thus is unlikely to be representative of the general popu-
lation), and QResearch [9] collects GP reported but not
patient reported data. The South Yorkshire Cohort dif-
fers from these existing data sources in that it will pro-
vide an infrastructure which combines the strengths of
the standard observational, longitudinal cohort study
design coupled with a facility for multiple randomised
controlled trials (see Figure 1). Additional qualitative
and observational quantitative projects will also be able
to be nested within this facility.
Thus the aim of this innovative population based
‘cohort trials facility’ is to build research capacity across
policy and research agendas, enable evaluation of poli-
cies aimed at tackling obesity including impact on
health inequalities, enable the evaluation of natural
experiments and the long term impact of interventions,
including clinical and cost effectiveness.
Study aims
The broad aims of the South Yorkshire Cohort are to:
￿ initiate a programme of research into the manage-
ment and self-management of weight and long term
conditions in adults in South Yorkshire
￿ to explore the relationship between key variables
from an NHS perspective: long term chronic dis-
ease, weight change, quality of life, prescribed and
over the counter medication, NHS and non NHS
healthcare resource use and ethnicity and social
class
￿ provide a cohort facility for multiple trials of inter-
ventions for the management and self- management
of weight and long term chronic health conditions
￿ provide a research facility for longitudinal and qua-
litative studies in weight and long term conditions
The specific research objectives agreed as of 27
th June
2011 by the South Yorkshire Cohort Management
Group are as follows:
1. To report the prevalence of long term health con-
ditions and associated variables
2. To report the prevalence of obesity and over-
weight and associated variables
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ment and self-management strategies self reported
by the South Yorkshire adult population
4. To provide a detailed profile of the health and
weight of underweight, normal weight, overweight,
obese and morbidly obese patients registered with
each participating GP practice, plus the types of ser-
vices and treatments used by patients to manage their
weight
5. To evaluate the clinical and cost effectiveness of
potential weight management interventions for obese
and overweight individuals and populations
6. To investigate the natural course of obesity and
the effect of particular variables on health outcomes
associated with obesity and its self-management
Method/Design
Study design
The South Yorkshire Cohort uses the cohort multiple
randomised controlled trial (cmRCT) design [10] (see
Figure 1). Key features of this design are:
(I) Recruitment of a large observational cohort of
patients with condition(s) of interest
(II) Regular outcome measurement for the whole
cohort
(III) Capacity for multiple RCTs over time
(IV) For each RCT, all eligible patients in the cohort
are identified (NA)
(V) Random selection of some eligible patients (nA),
and trial treatment offered
(VI) Outcomes of randomly selected patients (nA) are
compared to usual care i.e. the outcomes of those eligi-
ble patients not randomly selected (NA - nA)
(VII) ‘Patient centred’ informed consent i.e. patient
information and consent aim to replicate that of real
world routine healthcare.
The benefits of using the cmRCT design will help
address some of the shortcomings that prevent many
pragmatic randomised controlled trials fulfilling their
potential of giving robust evidence that clinicians can
apply to their clinical populations. In comparison to
randomised controlled trials, longitudinal observational
studies can recruit a greater quantity of patients and
more representative samples of patients. By separating
consent to take part in the observational cohort from
consent to ‘try’ a particular intervention, the staged and
‘patient centred’ information and consent procedures
that exist in routine healthcare are replicated. This
ensures a more ethical research design and one where
patient preferences are minimally affected by the
research design. Moreover, in comparison to the current
 
South Yorkshire Cohort: a large observational cohort (N) 
Random selection of some eligible 
patients (nA) and outcomes 
compared with those not 
receiving usual care (NA-nA) 
Random selection of some eligible 
patients (nA) and outcomes 
compared with those not 
receiving usual care (NA-nA) 
Eligible patients identified (NB) 
Eligible patients identified (NA) 
Regular    outcome    measurement 
Figure 1 South Yorkshire Cohort: a ‘cohort trials facility’ study of health and weight.
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provides important additional benefits:
￿ a multiple randomised controlled trial facility
￿ long term outcomes as standard
￿ ongoing information as to the natural history of
the condition(s) and treatment as usual
￿ increased comparability between each trial con-
ducted within the cohort
￿ increased efficiency, particularly for expensive or
high risk interventions
￿ rapid and cheap identification and recruitment of
patients
The ‘cmRCT’ design enables more reliable direct and
indirect comparisons than is currently possible because all
treatments have the same treatment as usual (i.e. standard
care) comparator and use the same core outcomes [10].
Standard randomised controlled trial designs often strug-
gle to recruit and consequently have to randomly allocate
all patients using equal randomisation to maximise statisti-
cal power within their total sample size. The large num-
bers of patients recruited to the cohort enables trials to
have increased statistical power and/or unequal randomi-
sation resulting in either strengthened inferences and/or
lower total treatment costs than standard trial designs and
significant cost savings for trials of expensive treatments.
Because of the large cohort, unequal randomisation can be
used more easily (i.e., randomise more to the inexpensive
treatment group), which improves the efficiency of trials
of high cost interventions compared to equal allocation.
Furthermore, information on those who decline treatment
provides information as to the acceptability of the treat-
ment and thus the generalisability of the trial results. Once
the cohort is established it potentially allows for rapid and
cheap identification and recruitment of patients.
The application of the cmRCT design to the question of
obesity and other long term chronic conditions will enable
both ongoing surveillance and evaluation of the clinical
and cost effectiveness of interventions in South Yorkshire,
together with a resource for research and a facility for test-
ing interventions for obesity and other chronic conditions.
Study setting
South Yorkshire is a metropolitan county in the York-
shire and Humber region of England with a population
of 1.29 m in three metropolitan boroughs (Barnsley,
Rotherham, Doncaster), and the city of Sheffield. In
2008, a quarter of adults in England (24% of men and
25% of women aged 16 or over) were classified as obese
(Body Mass Index ≥30 kg/m
2) [11], however much of
South Yorkshire has higher rates (Barnsley 28.4%, Don-
caster 29%, Rotherham 27.6%, Sheffield 23.7%) [12].
Study sample
The target population is all patients registered with GP
practices in South Yorkshire aged 16 to 85 years. We use
a two stage sampling method, which initially recruits GP
practices and then recruits patients registered with these
practices. Forty practices from South Yorkshire will be
recruited and eligible patients are invited to participate in
the South Yorkshire Cohort.
Eligibility criteria
All patients registered with the recruited GP practices
aged 16 to 85 years will be eligible for inclusion in the
South Yorkshire Cohort study. Eligibility criteria for stu-
dies embedded within the South Yorkshire Cohort will
vary.
Sample size
Cohort studies vary considerably in size. The purpose of
the South Yorkshire Cohort study is to provide a cohort
facility for multiple trials and other studies, thus the
cohort sample size has been calculated in order to provide
amongst other things a sufficient number of overweight,
obese and morbidly obese patients for a range of rando-
mised controlled trials to be conducted. We aim to recruit
a total of 20,000 adults to the South Yorkshire Cohort
multiple trials facility, which will provide an estimated
6,800 overweight adults, 4,400 obese adults and 400 mor-
bidly obese adults.
Recruitment
Recruitment began in June 2010 and is planned to con-
tinue until November 2012. GP practices are recruited by
email, letter and phone (Additional File 1). Recruited GP
practices send out an invitation letter (Additional File 2)
to all their eligible patients. Postage stamps rather than
prepaid envelopes are used to make the envelope appear
less official and more personal and thus help improve the
response rate [13]. The personalised invitation letter pro-
vides the patient with information about the study. Also
enclosed is the South Yorkshire Cohort ‘Health Question-
naire’ (Additional File 3). Patients are also offered access
to an online version of the Health Questionnaire available
at: http://www.syc.shef.ac.uk. The ethnicity of South York-
shire is 95.0% White, 2.6% Asian, and 2.4% Black and
many languages are spoken including Polish, Czech, Slova-
kian, Urdu, Punjabi, and Russian. For those patients
unable to read English, an additional A4 sheet explains in
12 languages how patients can obtain the Health Ques-
tionnaire translated into their language.
A unique study number is assigned to each Health
Questionnaire recipient. Each GP surgery stores a list of
unique study numbers and the associated patient data
( n a m e s ;a d d r e s s e s ;p o s t c o d e s ;N H Sn u m b e r s ;d a t eo f
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completed Health Questionnaires either on paper or
online.
Routine data collected: Health Questionnaire (patient
completed)
The South Yorkshire Cohort is collecting two types of
data: patient completed data and NHS generated data.
Patient generated data is collected by postal and internet
self completed questionnaire. As there was no generic
questionnaire which covered all the study questions, an
A4 size ‘Health Questionnaire’ was designed specifically
for this study (Additional File 3). In the first instance the
Health Questionnaire is sent out to patients from
recruited GP practices with the Invitation letter from their
GP practice (Additional File 2). In the Health Question-
naire there are 31 questions addressing specific issues
using single or multiple choice closed format questions.
These questions are described on 6 sides of A4 using the
headings: About you, Your health, Your exercise and food,
Your health care, You and your education, You and your
work. The origins of the Health Questionnaire questions
are described in Additional File 4.
About you
On the first page, demographic information as to gender,
date of birth, and how many children they have (under 18
years) is sought. Body Mass Index (BMI) is calculated
from patient’s self-reported height and weight. Informa-
tion on waist to height ratio is a better predictor of
chronic diseases than BMI for many patients [14], thus
patients are also asked to report their waist measurement
(a paper tape measure is included with the Health Ques-
tionnaire). Ethnicity is collected using the 17 Census 2001
categories in line with the Race Relations (Amendment)
Act 2000 which requires public bodies to take account of
race equality in policy making and service delivery.
Patients are also asked “Thinking about your own life and
personal circumstances, how satisfied are you with your life
as a whole?” and asked to respond to a 10 point lickert
scale (0 = Completely dissatisfied and 10 Completely
satisfied).
Your health
Patients’ health related quality of life’ is assessed using the
EuroQoL-5D (EQ-5D) [15] which is the most commonly
used generic ‘health related quality of life’ instrument.
Respondents are asked one question relating to the follow-
ing five health dimensions: mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. The
responses to these questions are used together with the
associated preference-based algorithm [16] to generate a
preference-based utility measure (anchored at 1 for full
health and zero for death with negative values represent-
ing health states considered to be worse than death). The
resulting index (range -0.59 to 1) is the preferred utility
measure to generate quality adjusted life years in cost
effectiveness analyses submitted to NICE in the UK. EQ-
5D has been shown to be sensitive to the health related
quality of life effects of obesity [17].
Patients are asked if they “have any long-standing illness,
health problem, condition or disability?” and the following
categories supplied: ‘tiredness/fatigue’, ‘pain’, ‘insomnia’,
‘anxiety/nerves’, ‘depression’, ‘diabetes’, ‘breathing problems
e.g. chronic bronchitis, asthma or emphysema’, ‘high blood
pressure’, ‘heart disease’, ‘osteoarthritis’, ‘stroke’, ‘cancer’,
‘other’. Patients are also asked about alcohol consumption
in the last week and smoking status.
From an NHS perspective, as the main provider of medi-
cines, there is a strong rationale for understanding more
about use of medicines from an individual perspective and
their relationship with patterns of obesity and patterns of
other NHS resource use. This study will collect estimates
of the amount of prescribed and over the counter medi-
cines, including those that are used for the treatment of
obesity (e.g. Orlistat), as well as those with weight gain
side effects (e.g. oral steroids). Although a mean 15 pre-
scriptions per person per annum are made in the UK
community [18] there is little information on the effects of
combining medications and thus their combined effect on
obesity.
Patients are asked whether they are currently taking any
medication and to provide information on both prescribed
and self prescribed medication including name and
strength of tablet, medicine, ointment, drops, inhaler or
injection; whether it is prescribed or not; and what this is
for. As no validated questionnaire for patient reported
medication use was identified, an existing validated Medi-
cation Change Questionnaire [19] was adapted. The Medi-
cation Change Questionnaire [19] provides people with a
simple structured form on which to record their medica-
tion use for seven days. In order to increase questionnaire
response rates, the Medication Change Questionnaire has
been modified by asking patients to record general daily
use rather than use over 7 days.
Your exercise and food
Information on the extent to which respondents are
physically active is collected using the following question
from the Department of Health’s General Practice Physi-
cal Activity Questionnaire [20]: A screening tool to
assess adult physical activity levels, within primary care”
“During the last WEEK, how many hours did you spend
on each of the following activities?: Physical exercise such
a ss w i m m i n g ,j o g g i n g ,a e r o b ics, football, tennis, gym,
workout etc. Cycling, including cycling to work and dur-
ing leisure time. Walking, including walking to work,
shopping, for pleasure etc”.
Patients are also asked “Is managing your weight a
concern for you?” and to report whether they have ever
used the following interventions to help manage their
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your portion size, a slimming club, over the counter
weight loss medication or meal replacements.
Your healthcare
In addition to the medication question, additional NHS
and non NHS healthcare resource use is collected on hos-
pital visits, GP visits and other healthcare visits (nurse,
physiotherapist, dietician, midwife, mental health worker,
psychotherapist, counsellors, care worker, social worker,
health visitor, community health champion, health trainer
and alternative therapist (acupuncturist, chiropractor,
herbalist, homeopath, and osteopath).
You and your education
patients are asked which educational qualifications they
have.
You and your work
In order to collect information on socio-economic sta-
tus, the self-coded version of the National Statistics
Socio-economic Classification (NS-SEC) [21] is included.
This is a flexible and structured, occupation based classi-
fication but has rules to provide coverage of the whole
adult population. Patients are also asked how many days
off from work or households tasks or leisure activities
they have taken as a result of ill health.
Routine data collected: NHS generated data
For those patients who provide consent to access to their
‘NHS health records (your prescriptions, diagnoses and GP/
hospital visits)’, NHS generated data on individual patients
will be collected through searches of GP databases using
local codes created for the study. Each GP clinical system
will be searched in order to generate information on the
following NHS generated data: age, sex, disease diagnoses
associated with obesity (type II diabetes, chronic obstruc-
tive pulmonary disease, stroke, coronary heart disease,
cancer, high blood pressure, and osteoarthritis), drug
information, number of consultations in the last year, and
number of referrals in the last year.
Response rate
This study aims to maximise the response rate to the
Health Questionnaires, in order to minimise differences
between the study population and the reference (general)
population. Based on reported response rates to previous
postal questionnaires e.g. 60% [22], 66% [23] and 49% [24]
and a 60% response rate to a Sheffield population based
survey of 3,000 patients aged 18 - 95 [25], we anticipated a
response rate of 45 - 50%.
Research Governance and confidentiality
Research governance approval has been obtained from
each of the four Primary Care Trusts (Sheffield, Barnsley,
Rotherham, and Doncaster). Data will be held for 35
years (15 years beyond the proposed 20 year lifespan of
t h ec o h o r t ) .D a t am a n a g e m e n tw i l lb ep r o v i d e db yt h e
University of Sheffield Clinical Trials Research Unit
(CTRU) who adhere to their own Standard Operating
Procedures (SOPs) relating to all aspects of data manage-
ment including data protection and archiving.
Data quality and data management
The CTRU uses the ‘Prospect’ data management system
for the capture and storage of this data. Prospect stores all
data in a PostgreSQL database on virtual servers hosted by
Corporate Information and Computing Services at the
University of Sheffield. Prospect uses industry standard
techniques to provide security, including password
authentication and encryption using SSL/TLS. Prospect
uses a comprehensive privilege management feature to
ensure authorised individuals have access to only the mini-
mum amount of data required to complete their tasks,
thereby restricting access to patients’ personal identifiable
data. Areas of the system used to manage personal or sen-
sitive information require specific privileges to gain access.
In order to ensure the safety of this data it is encrypted
using AES256. The NHS number is encrypted using a one
way hashing function (SHA2). All other information,
except the unique study number, is encrypted using the
unhashed password (NHS number) as the key. When the
participant logs in to the online survey system their pass-
word is used to unencrypt the data from the upload. This
data is then used to pre-fill sections of the online entry
form (but is not stored at this stage). Upon completion of
each page of the form, the submitted data is then saved to
the server.
The participant is only allowed to log in during a defined
window (42 days from the date of upload). During this
time the participant is permitted to edit the information
they have submitted. Once this period has expired the
data will be available to the study database users. For
those patients who consent for the study team to have
access, data held by their GP or Health Authority will be
downloaded into electronic files and transferred to the
University of Sheffield Clinical Trials Research Unit. The
NHS Confidentiality Code of Practice (Nov 2003) [26] will
be followed.
Ethics approval and indemnity
NHS Research Ethics Committee approval for the South
Yorkshire Cohort protocol was obtained on 27
th April,
2010 (REC ref: 09/H1306/97).
Consent
A core feature of the cmRCT design is ‘patient centred
informed consent’ i.e. patient information and consent
aim to replicate that of real world routine healthcare
rather than conform to the needs of standard trial
designs. Therefore all cohort patients consent to provide
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for their information to be used to look at the benefit of
healthcare treatments; however, consent to “try” ap a r t i -
cular intervention in the future is sought only from those
offered that intervention. This method of obtaining con-
sent replicates the ‘patient centred’ information and con-
sent procedures that exist in routine health care, where
clinicians provide patients with the information they
need, at the time they need it. In this study if patients
provide all the following three consents (A, B and C) they
are then regarded as members of the South Yorkshire
Cohort.
￿ A: Health Questionnaire data to be used to ‘help
the NHS improve the long term health of people liv-
ing in South Yorkshire’. Information relating to this
consent is provided in the GP Invitation letter to
their patients (Additional File 2). Consent to provide
this data is implicit and signalled by return of the
Health Questionnaire to the researchers.
￿ B: Further contact from the researchers. This infor-
mation is provided in the Invitation letter from the
GP (Additional File 2) and consent is explicitly
sought on the back page of the Health Questionnaire
(Additional File 3).
￿ C: The information that patients provide to be used
‘to look at the benefit of health treatments’.I n f o r m a -
tion relating to this consent is provided in the Invita-
tion letter from GPs and is explicitly sought on the
back page of the Health Questionnaire.
In addition to consents A, B and C, supplementary
consent (D) is sought for:
￿ D: Access to ‘your health records’. Information
relating to this consent is provided in the GP Invita-
tion letter and on the back page of the Health
Questionnaire.
Consent to the possibility of random selection to any
future trial treatment is not sought. We suggest that it is
unethical to falsely raise expectations of trial treatments
when these expectations will not be fulfilled for the
majority of the South Yorkshire Cohort study population.
For example, if in the future 5 randomised controlled
trials are embedded within the South Yorkshire Cohort
(with for example 400 patients randomly selected to the
intervention arm in each trial), this would equate to
2,000 out of 20,000 patients randomly selected to try an
intervention and 18,000 not selected.
South Yorkshire Cohort Guardian
Lack of consent to randomisation from individuals is not
an insurmountable ethical issue for cluster randomised
controlled trials [27]. For cluster randomised controlled
trials, it is argued that the role of a Guardian is key to
their ethical conduct [28]. Leeds East NHS Research
Ethics Committee has effectively taken on the role of
guardian of the South Yorkshire Cohort. All studies
embedded or nested within the South Yorkshire Cohort
(including randomised controlled trial) are required to
obtain approval from Leeds East Research Ethics Com-
mittee. This will help ensure the safety and rights of
South Yorkshire Cohort members and manage the risk of
some groups being ‘over researched’.
Analysis plan
In order to ascertain the extent and type of any non
response bias at the population level, the responders and
non responders will be compared with regards to their GP
practice and their postcode, sex and age. Initial analyses
will be descriptive. Three different types of dataset will be
produced according to the type of consent given:
Survey
all completed returned Health Questionnaires (Consent
A).
Longitudinal observational study
all completed returned Health Questionnaires (Consent
A) with consent to be contacted again (Consent B).
Multiple Trials Facility
all completed returned Health Questionnaires (Consent A)
with consent to be contacted again (Consent B) and con-
sent for researchers to use the information they provide to
look at the benefit of health treatments (Consent C).
For each dataset, analysis of key variables will be
divided into six sections: height and weight will be used
to calculate BMIs for all patients and for purposes of ana-
lysis patients will then be divided into six groups accord-
ing to their reported BMI: underweight < 18.5, normal
18.5-24.9, overweight 25 -.29.9, obese 30 - 34.9, severely
obese 35 - 39.9, morbidly obese 40 - 49.9.
The following types of NHS and non NHS healthcare
r e s o u r c eu s ed a t aw i l lb ea n a lysed using descriptive sta-
tistics: medication (prescribed/self prescribed), hospital
visits, contacts with other healthcare providers, and
weight management strategies. Data will also be analysed
in order to identify any interventions that may promote
weight management. This will include cost effectiveness
analysis and modelling of potential interventions
(expected value of perfect information) to establish the
potential need for further research. The burden of obesity
in terms of economic costs will be estimated from a soci-
etal perspective. In order to make the results comparable
with NICE guidelines [29], an NHS and Personal Social
Services Prospective will also be undertaken, which will
not include production loss. Resource use profiles will be
used to calculate costs using national average unit costs
from routine sources, e.g. NHS reference costs for
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Research Unit costs of health and social care [31] such as
GP visits, physiotherapy sessions. Costs of non-NHS
interventions will be valued using market prices. Produc-
tion losses will comprise lost employment and changes in
employment as valued by the “New Earnings Survey”.
The EQ-5D will be analysed to provide estimates of
Health Related Quality of Life.
Results will be compared with those reported in the fol-
lowing relevant studies [8, 10 and 25]. For those patients
who consent to their NHS health records being searched
then further analyses will be conducted using informa-
tion on patients’: chronic disease status: as recorded by
GP including: diabetes, chronic obstructive pulmonary
disease, stroke, coronary heart disease, cancer; NHS
resource use: visits to NHS primary care healthcare pro-
fessionals, visits to NHS secondary care.
Study management
The South Yorkshire Cohort is hosted within the Obesity
T h e m eo ft h eN I H RC L A H R Cf o rS o u t hY o r k s h i r e[ 3 ] .
The Obesity Theme Advisory Group includes obesity
commissioners from each of the four South Yorkshire
NHS Primary Care Trusts, service providers, researchers
from both Sheffield universities, clinicians and the public
from across the region. This group provides an initial
scientific review function and performs a gatekeeper and
signposting role for internal and external enquiries for
access to South Yorkshire Cohort data.
South Yorkshire Cohort Management Group has respon-
sibility for overseeing the management of the study includ-
ing: monitoring study progress and advising on
modifications required, oversight of the study conduct,
strategic planning, planning grant applications, co-ordinat-
ing embedded study applications, oversight of the budget,
ensuring the study meets the requirements of Research
Governance and data protection, dissemination of results.
South Yorkshire Cohort Operation Group is responsible
for the day to day implementation of the study, including
co-ordination of the staff working on the project, recruit-
ment of GPs and patients, data management, and adher-
ence to the protocol.
Intellectual property and principles of collaboration
The South Yorkshire Cohort is assembling and obser-
ving longitudinally a cohort of NHS patients which will
provide the following benefits:
￿ ongoing population surveillance of adults of all
ages
￿ information on the natural history of the condition
(s) and any associated factors
￿ information on ‘treatment as usual’
￿ long term outcomes.
￿ longitudinal observational data
￿ a representative population based sample of adults
of all ages
￿ up to date information to facilitate evaluation as
well as hypothesis generation
￿ a multiple trials facility for hypothesis testing
￿ a recruitment facility for qualitative and quantita-
tive research studies
Researchers with proposals to conduct randomised con-
trolled trials embedded within the South Yorkshire Cohort
or longitudinal observational research or use cohort data
should read the guidance and conditions for studies utilis-
ing the South Yorkshire Cohort research facility and then
complete the outline proforma available on the South
Yorkshire Cohort website [http://clahrc-sy.nihr.ac.uk/
south-yorkshire-cohort.html]. Proposals will be reviewed
by the South Yorkshire Cohort Management Group. The
principles for agreeing a proposal and releasing data are
that the proposal (a) meets the broad aims of the South
Yorkshire Cohort study, (b) is scientifically rigorous and
practically feasible.
Discussion
This National Institute for Health research Collaborations
for Leadership in Applied Health Research and Care for
South Yorkshire funded study [3] is focussing on improv-
ing patient outcomes through the conduct and application
of applied health research and service design in the areas
of chronic long term conditions, self-management, health
inequalities and public health [32]. The South Yorkshire
Cohort uses the cmRCT design which combines the
strengths of the standard observational, longitudinal
cohort study design with a population based cohort facility
for multiple randomised controlled trials in a range of
long term health and weight related conditions (including
obesity). This infrastructure will allow the rapid and cheap
identification and recruitment of patients, and facilitate
the provision of robust evidence to inform the manage-
ment and self- management of health and weight.
Additional material
Additional File 1: Invitation to GPs letter. Letter inviting GPs to
participate in the study.
Additional File 2: GP Invitation letter to their patients. Letter from
GPs to their patients inviting them to participate in the study.
Additional File 3: Health Questionnaire. Health Questionnaire
(including consent form) sent to patients.
Additional File 4: Origins of Health Questionnaire questions. The
origins of the questions in the Health Questionnaire are described.
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